JPS62709B2 - - Google Patents
Info
- Publication number
- JPS62709B2 JPS62709B2 JP56141918A JP14191881A JPS62709B2 JP S62709 B2 JPS62709 B2 JP S62709B2 JP 56141918 A JP56141918 A JP 56141918A JP 14191881 A JP14191881 A JP 14191881A JP S62709 B2 JPS62709 B2 JP S62709B2
- Authority
- JP
- Japan
- Prior art keywords
- magnetic
- magnetic field
- medical device
- magnet
- needle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000005291 magnetic effect Effects 0.000 claims description 91
- 230000005426 magnetic field effect Effects 0.000 claims description 2
- 238000001467 acupuncture Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 13
- 239000004809 Teflon Substances 0.000 description 13
- 229920006362 Teflon® Polymers 0.000 description 13
- 230000036407 pain Effects 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- 239000004973 liquid crystal related substance Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 230000005684 electric field Effects 0.000 description 8
- 230000005389 magnetism Effects 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 6
- 239000010408 film Substances 0.000 description 5
- AJCDFVKYMIUXCR-UHFFFAOYSA-N oxobarium;oxo(oxoferriooxy)iron Chemical compound [Ba]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O AJCDFVKYMIUXCR-UHFFFAOYSA-N 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- 239000003989 dielectric material Substances 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 239000004575 stone Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000001678 irradiating effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 229940034208 thyroxine Drugs 0.000 description 3
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 3
- 229910000828 alnico Inorganic materials 0.000 description 2
- 239000004981 biological liquid crystal Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 238000005421 electrostatic potential Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- 239000005083 Zinc sulfide Substances 0.000 description 1
- 229910052946 acanthite Inorganic materials 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- KPLQYGBQNPPQGA-UHFFFAOYSA-N cobalt samarium Chemical compound [Co].[Sm] KPLQYGBQNPPQGA-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000005292 diamagnetic effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229940035422 diphenylamine Drugs 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000005674 electromagnetic induction Effects 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000009828 non-uniform distribution Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920013716 polyethylene resin Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000938 samarium–cobalt magnet Inorganic materials 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- XUARKZBEFFVFRG-UHFFFAOYSA-N silver sulfide Chemical compound [S-2].[Ag+].[Ag+] XUARKZBEFFVFRG-UHFFFAOYSA-N 0.000 description 1
- 229940056910 silver sulfide Drugs 0.000 description 1
- 229910052596 spinel Inorganic materials 0.000 description 1
- 239000011029 spinel Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
- DRDVZXDWVBGGMH-UHFFFAOYSA-N zinc;sulfide Chemical compound [S-2].[Zn+2] DRDVZXDWVBGGMH-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Electrotherapy Devices (AREA)
- Magnetic Treatment Devices (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56141918A JPS5832776A (ja) | 1981-09-09 | 1981-09-09 | 磁石を小型化した装身具型磁気医療具 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56141918A JPS5832776A (ja) | 1981-09-09 | 1981-09-09 | 磁石を小型化した装身具型磁気医療具 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5832776A JPS5832776A (ja) | 1983-02-25 |
| JPS62709B2 true JPS62709B2 (cs) | 1987-01-09 |
Family
ID=15303185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56141918A Granted JPS5832776A (ja) | 1981-09-09 | 1981-09-09 | 磁石を小型化した装身具型磁気医療具 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5832776A (cs) |
-
1981
- 1981-09-09 JP JP56141918A patent/JPS5832776A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5832776A (ja) | 1983-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kirson et al. | Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors | |
| Rosen et al. | Magnetic field influence on central nervous system function | |
| US6447499B2 (en) | Use of a polarized field to modify the efficacy of a bioactive agent | |
| Kranjc et al. | Electrochemotherapy by pulsed electromagnetic field treatment (PEMF) in mouse melanoma B16F10 in vivo | |
| Omura | Electro-acupuncture: its electro-physiological basis and criteria for effectiveness and safety—part I | |
| US20090306456A1 (en) | Apparatus and method for static magnetic field treatment of tissue, organs, cells, and molecules | |
| JPH0321190B2 (cs) | ||
| US7601114B2 (en) | Apparatus and method for enhancing tissue repair in mammals | |
| WO2006060304A2 (en) | Method and apparatus for therapeutic treatment of inflammation and pain with low flux density, static electro-magnetic fields | |
| KR100950795B1 (ko) | 전자기장 중복 출력 치료기 | |
| JPH10230018A (ja) | 電気治療具，皮膚貼着用帯電盤付きバンド及び電荷注入器 | |
| US3769985A (en) | Electrostatic treatment apparatus with charge disperal means | |
| KR102505966B1 (ko) | 자석 마사지기 | |
| JPS62709B2 (cs) | ||
| Polk | Biological applications of large electric fields: Some history and fundamentals | |
| JPH027973A (ja) | 磁石治療装置 | |
| US12208276B2 (en) | Method and apparatus generator, concentrator and router of electromagnetic fields for cellular regeneration | |
| CN105361308A (zh) | 贴身健康理疗自律功能腰带 | |
| Sun et al. | The effect of magnetic coil orientation on the excitation of the median nere | |
| RU2029573C1 (ru) | Аппарат для физиотерапевтического лечения | |
| Tenforde | The wonders of magnetism | |
| RU2005504C1 (ru) | Устройство для электротерапии | |
| Driban | Bone Stimulators and Microcurrent: Clinical Bioelectrics. | |
| Turrell | The principles of electrotherapy and their practical application | |
| RU2080850C1 (ru) | Способ лечения невралгий |